Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 4 | BMC Immunology

Fig. 4

From: Macrophage-targeted anti-CCL2 immunotherapy enhances tumor sensitivity to 5-fluorouracil in a Balb/c-CT26 murine colon carcinoma model measured using diffuse reflectance spectroscopy

Fig. 4

Combination therapy shows decrease in total and M2 macrophage recruitment. A Total TAM recruitment through IHC quantification using CD68 (40X, scale bars are 20 μm). B M2 TAM recruitment through IHC quantification using CD163. The average number of positively stained C CD68 (n = 27 FOVs per group) and D CD163 (n = 27 FOVs per group). TAMs were counted per FOV. Then the E ratio of M2 TAMs to total TAMs was calculated. A mixed effects model was used to calculate statistical differences (*p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001). Plots created in Prism (GraphPad)

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us